Accessibility Statement Skip Navigation
  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing
  • Login
  • GDPR
  • Create a Free Account
Return to PRWeb homepage
  • News
  • Resources
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
  • Business & Money
      • Auto & Transportation

      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Hamburger menu
  • Cision PRWeb provides efficient communication tools to continuously engage with target audiences across multiple online channels
  • Create a Free Account
    • ALL CONTACT INFO
    • Contact Us


      11AM ET Sunday – 8PM ET Friday

  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • News in Focus
    • Browse All News
    • Multimedia Gallery
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR

1st ReLEx/SMILE Procedure Done in the USA, Post-FDA Approval, Performed by Jon G. Dishler, M.D., of Denver, Colorado
  • USA - English


News provided by

[email protected]

Mar 07, 2017, 03:00 ET

Share this article

Share toX

Share this article

Share toX


Denver, Colorado (PRWEB) March 07, 2017 -- After personally working for almost 10 years on the next big advancement in laser vision correction, Jon Dishler M.D., became the first surgeon in America to perform the 1st ReLEx/SMILE procedure on a patient, Kierra Montano, post FDA approval on March 3, 2017.

With hundreds of SMILE procedures under his belt, this new breakthrough procedure is now available to patients at Dishler Laser Institute.

"We are thrilled that this exciting new technology is finally available to surgeons and patients in the U.S. It is a new and appealing option for many who have concerns about the existing choices for surgical vision correction."

Post this

During this long development, and over the last several years the Zeiss VisuMax technology was approved in virtually all the rest of the world, and as a result, there now have been over 1 million ReLEx/SMILE procedures performed. That’s a lot of procedures and should help ease the minds of anyone who is concerned about trying something new.

So what is this new procedure? It is called ReLEx SMILE. It really could be called either, but Zeiss, who are the "brains" that invented this technology, wanted to use both names. ReLEx stands for refractive lens extraction, and SMILE means small incision lenticule extraction. So what is this all about?

Most have heard of LASIK, where a corneal flap is made, with either a blade or a laser, and then after peeling back the flap, the inner surface of the cornea is treated with another type of laser, an excimer laser, to reshape the eye. All of this has scared many of the faint of heart away from LASIK. Some just don’t like the idea of a flap. Nonetheless, many, especially the so-called Millennials, have been waiting for the next generation procedure to show itself.

Enter SMILE. Here, a tiny incision can be used to remove a very small piece of tissue that is cut by the laser, to restore vision, and without a flap! The laser, made only by Zeiss, is called appropriately enough, the VisuMax. In about 35 seconds, the laser precisely cuts the shape of a small contact lens from within the cornea, and then the surgeon removes this piece of tissue. The eye is permanently reshaped, to a front surface which is very similar to that obtained by wearing a soft contact lens, and clear vision is restored.

Currently ReLEx SMILE is approved for about 99% of all nearsightedness cases, so even very bad eyes can be fixed. It does not yet correct astigmatism, but another study, that is almost complete, will hopefully expand the range to include these people also. When this happens we will have a viable alternative to LASIK for almost everyone seeing laser vision correction.

So how were the results. In a word, they were great. Both the vision results were superb, the complications were few, and about the experience of study subjects revealed that most everyone was very satisfied.

What does Dr. Jon G. Dishler have to do with all of this? He was the medical monitor for the Zeiss VisuMax myopia study, overseeing and stewarding the study before, during, and after to this point of approval. Dr. Dishler and staff treated their fair share of the patients as an investigative site. They learned first-hand in both this study, and the astigmatism one that followed, just what makes this procedure work well, and they are happy to make it available to the right people very soon.

Who are these “right people”? Part of this is easy, it is the people who fit the criteria of any voluntary refractive eye surgery, of healthy eyes other than nearsightedness. In addition, such folks as policemen/women, firefighters, avid sports nuts, and anyone who might get hit in the eye makes the most sense. This is why the US military is so excited about ReLEx SMILE, and why they are starting their own study very soon for military personnel. Their study will bring further validation to the process, since people like pilots and combat ready troops will be treated.

How available is the ReLEx/SMILE vision correction procedure? To begin with, the ReLEx/SMILE will be offered by the six investigative sites, including Dr. Dishler, then a select group of prestigious doctors and institutions, and a short time later it will be rolled out to several doctors in most communities throughout the country. A year from now this should be widely available.

If you have an interest in finding out if you are a good candidate for this new refractive procedure, then please make an appointment for a consultation with Dishler Laser Institute. Come on in for a chat. They will let you know if the SMILE laser eye correction procedure is for you.

Rachel Gomez, M.S.N., [email protected], http://www.dishler.com, +1 303-793-3000, [email protected]

Modal title

ReLEx SMILE: Flapless. All-femto. Single-step
ReLEx SMILE: Flapless. All-femto. Single-step
ReLEx SMILE: Flapless. All-femto. Single-step

Contact PRWeb

  • 11AM ET Sunday – 8PM ET Friday
  • Contact Us

About PRWeb

  • About PRWeb
  • Partners
  • Partnership Programs
  • Editorial Guidelines
  • Resources

Why PRWeb

  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing

Accounts

  • Create a Free Account
  • Log in
  • Contact Us

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact Cision

Products

About

My Services
  • All News Releases
  • Online Member Center
  • ProfNet
Cision Distribution Helpline
888-776-0942
  • Legal
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 Cision US Inc.